JPRN-UMIN000023044已完成未知
The efficacy and safety in canaglifrozin therapy for diabetes complicated by non-alcoholic fatty liver disease. - The efficacy of Canaglifrozin for NAFLD.
Kyoto prefetural University of Medicine0 个研究点目标入组 20 人开始时间: 2016年10月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •administration of SGLT2 inhibitors type 1 diabetes platelet count<100000/microL eGFR<45m/min/1.73m2 diagnosed heart failure or malignancy
研究者
相似试验
招募中
不适用
The efficacy and safety of Canagliflozin for the treatment of NAFLD/NASH patients with type2 DMAFLD/NASHJPRN-UMIN000036560ippon Medical School Chiba Hokusoh Hospital Division of Gastroenterology30
已完成
4 期
A clinical trial to compare the effects of Canagliflozin and Sitagliptin in Patients with Type 2 Diabetes mellitus on a background metformin therapy.CTRI/2019/02/017435SRM College of Pharmacy40
尚未招募
不适用
Effect of canagliflozin as an alternative drug from DPP-4 inhibitor on heart failure with diabetis melltus : the pilot study "Can canagliflozin HAve Not only hypoGlycemic but cardiac supportive Effect?"chronic heart failure with type 2 diabetis mellitusJPRN-UMIN000031563Osaka Rosai Hospital40
已完成
不适用
Study of the beneficial effect of Canagliflozin on nocturnal home BP in Japanese T2DM patients(SHIFT-J STUDY)Type 2 diabetes mellitus patients with hypertensionJPRN-UMIN000023487Jichi Medical University School of Medicine100
已完成
不适用
The effect of canagliflozin on the blood sugar levels of people without diabetes after weight loss surgeryHypoglycaemia after eating due to weight-loss surgerySurgeryISRCTN11342830niversity of Leicester36